HTGF | High-Tech Gruenderfonds

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Kay Balster

Senior Investment Manager

Jens Baumgärtner

Senior Investment Manager

Anke Cassing

Principal

Tanja Emmerling

Partner / Head HTGF Berlin

Caroline Fichtner

Senior Investment Manager

Yann Fiebig

Investment Manager

Dr. Alex von Frankenberg

Managing Director and Founder

Bernd Goergen

Partner

Frank Hensel

Senior Investment Manager

Markus Kressmann

Partner

Lena Krzyzak

Principal

Maurice Kügler

Investment Manager

Klaus Lehmann

Senior Investment Manager

Dominik Lohle

Senior Investment Manager

Curtis MacDonald

Venture Partner

Andreas Olmes

Partner

Katharina Peters

Investment Manager

Martin Pfister

Senior Investment Manager

Claudia Raber

Partner

Guido Schlitzer

Managing Director

Ulrich Schmitt

Principal

Romy Schnelle

Partner

Clemens Von Bergmann

Investment Director

Axel Nitsch

Investment Manager

Tobias Schulz

Principal

Past deals in Wearables

Avelios Medical

Series A in 2025
Avelios Medical operates a modular clinic platform designed to enhance patient care by digitizing and optimizing clinic processes. The platform offers user-friendly software that supports healthcare staff in their daily operations while facilitating the integration of innovative technologies such as artificial intelligence, big data, telemedicine, patient applications, and wearables. By streamlining workflows and automating various tasks, Avelios Medical aims to significantly improve both patient outcomes and healthcare research, making it a valuable resource for hospitals and clinics seeking to modernize their services.

Synthara

Venture Round in 2024
Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.

InContAlert

Pre Seed Round in 2023
inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder. -- no more unnecessary catheters. no more needless emptying through nurses. no more diapers -- inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is then displayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.

Avelios Medical

Seed Round in 2021
Avelios Medical operates a modular clinic platform designed to enhance patient care by digitizing and optimizing clinic processes. The platform offers user-friendly software that supports healthcare staff in their daily operations while facilitating the integration of innovative technologies such as artificial intelligence, big data, telemedicine, patient applications, and wearables. By streamlining workflows and automating various tasks, Avelios Medical aims to significantly improve both patient outcomes and healthcare research, making it a valuable resource for hospitals and clinics seeking to modernize their services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.